Cargando…

Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease

BACKGROUND/AIM: We aimed to evaluate the prevalence of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease (COPD). MATERIALS AND METHODS: This cross-sectional study was performed on 219 patients aged 50 years and over who were diagnosed with chronic obstructive...

Descripción completa

Detalles Bibliográficos
Autores principales: DEMİRCİOĞLU, Havva, CİHAN, Fatma Gökşin, KUTLU, Ruhuşen, YOSUNKAYA, Şebnem, ZAMANİ, Adil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491298/
https://www.ncbi.nlm.nih.gov/pubmed/32421282
http://dx.doi.org/10.3906/sag-1909-36
_version_ 1783582194811273216
author DEMİRCİOĞLU, Havva
CİHAN, Fatma Gökşin
KUTLU, Ruhuşen
YOSUNKAYA, Şebnem
ZAMANİ, Adil
author_facet DEMİRCİOĞLU, Havva
CİHAN, Fatma Gökşin
KUTLU, Ruhuşen
YOSUNKAYA, Şebnem
ZAMANİ, Adil
author_sort DEMİRCİOĞLU, Havva
collection PubMed
description BACKGROUND/AIM: We aimed to evaluate the prevalence of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease (COPD). MATERIALS AND METHODS: This cross-sectional study was performed on 219 patients aged 50 years and over who were diagnosed with chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. The study included 196 (89.5%) male and 23 (10.5%) female patients. The mean age of the patients was 66.9 ± 10.1 years. To diagnose sarcopenia, muscle function was determined by a gait speed test. Muscle strength was assessed with a hand dynamometer and muscle mass was measured with a bioelectrical impedance analysis device. Pulmonary function tests and six-min walking tests were also performed. The modified Medical Research Council (mMRC) dyspnoea scale was used to evaluate all the participants. Our sample consisted of sarcopenic patients at different stages (17 presarcopenic patients (7.8%), 32 patients with sarcopenia (14.6%), 65 patients with severe sarcopenia (29.7%), and 105 nonsarcopenic patients (47.9%). RESULTS: Sarcopenia was significantly associated with age, BODE (body mass index (BMI), airflow obstruction, dyspnoea, and exercise capacity) index, GOLD spirometric classification, mMRC dyspnoea scale score, BMI, and educational status. Sarcopenia in COPD patients was firmly related to the severity of the disease and its prognosis. The prevalence of sarcopenia increased in severe and very severe COPD cases. The dyspnoea score was higher, and exercise capacities were lower in sarcopenic patients. CONCLUSIONS: Sarcopenia in COPD patients was closely related to the severity of COPD and a negative prognosis. The frequency of sarcopenia increased in severe and very severe COPD cases. Dyspnoea scores were higher and exercise capacities were lower in patients with sarcopenia. In patients with COPD, a diagnosis of sarcopenia should be considered, and preventive measures should be taken before irreversible changes develop.
format Online
Article
Text
id pubmed-7491298
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Scientific and Technological Research Council of Turkey
record_format MEDLINE/PubMed
spelling pubmed-74912982020-09-16 Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease DEMİRCİOĞLU, Havva CİHAN, Fatma Gökşin KUTLU, Ruhuşen YOSUNKAYA, Şebnem ZAMANİ, Adil Turk J Med Sci Article BACKGROUND/AIM: We aimed to evaluate the prevalence of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease (COPD). MATERIALS AND METHODS: This cross-sectional study was performed on 219 patients aged 50 years and over who were diagnosed with chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. The study included 196 (89.5%) male and 23 (10.5%) female patients. The mean age of the patients was 66.9 ± 10.1 years. To diagnose sarcopenia, muscle function was determined by a gait speed test. Muscle strength was assessed with a hand dynamometer and muscle mass was measured with a bioelectrical impedance analysis device. Pulmonary function tests and six-min walking tests were also performed. The modified Medical Research Council (mMRC) dyspnoea scale was used to evaluate all the participants. Our sample consisted of sarcopenic patients at different stages (17 presarcopenic patients (7.8%), 32 patients with sarcopenia (14.6%), 65 patients with severe sarcopenia (29.7%), and 105 nonsarcopenic patients (47.9%). RESULTS: Sarcopenia was significantly associated with age, BODE (body mass index (BMI), airflow obstruction, dyspnoea, and exercise capacity) index, GOLD spirometric classification, mMRC dyspnoea scale score, BMI, and educational status. Sarcopenia in COPD patients was firmly related to the severity of the disease and its prognosis. The prevalence of sarcopenia increased in severe and very severe COPD cases. The dyspnoea score was higher, and exercise capacities were lower in sarcopenic patients. CONCLUSIONS: Sarcopenia in COPD patients was closely related to the severity of COPD and a negative prognosis. The frequency of sarcopenia increased in severe and very severe COPD cases. Dyspnoea scores were higher and exercise capacities were lower in patients with sarcopenia. In patients with COPD, a diagnosis of sarcopenia should be considered, and preventive measures should be taken before irreversible changes develop. The Scientific and Technological Research Council of Turkey 2020-08-26 /pmc/articles/PMC7491298/ /pubmed/32421282 http://dx.doi.org/10.3906/sag-1909-36 Text en Copyright © 2020 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Article
DEMİRCİOĞLU, Havva
CİHAN, Fatma Gökşin
KUTLU, Ruhuşen
YOSUNKAYA, Şebnem
ZAMANİ, Adil
Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease
title Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease
title_full Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease
title_fullStr Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease
title_full_unstemmed Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease
title_short Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease
title_sort frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491298/
https://www.ncbi.nlm.nih.gov/pubmed/32421282
http://dx.doi.org/10.3906/sag-1909-36
work_keys_str_mv AT demirciogluhavva frequencyofsarcopeniaandassociatedoutcomesinpatientswithchronicobstructivepulmonarydisease
AT cihanfatmagoksin frequencyofsarcopeniaandassociatedoutcomesinpatientswithchronicobstructivepulmonarydisease
AT kutluruhusen frequencyofsarcopeniaandassociatedoutcomesinpatientswithchronicobstructivepulmonarydisease
AT yosunkayasebnem frequencyofsarcopeniaandassociatedoutcomesinpatientswithchronicobstructivepulmonarydisease
AT zamaniadil frequencyofsarcopeniaandassociatedoutcomesinpatientswithchronicobstructivepulmonarydisease